Company news

OPKO Health, Inc. news in 2026

OPKO Health, Inc.'s news releases, calls and decks from 2026, newest first.

View company

OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results

November 4, 2026

OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026

October 28, 2026

OPKO Health’s OPKO Biologics Doses First Participant in Phase 1/2a Trial of OPK-8801001 for Acromegaly

October 27, 2026

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

October 15, 2026

OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

September 8, 2026

OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests

August 13, 2026

OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results

July 27, 2026

OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026

July 23, 2026

Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026

June 15, 2026

OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

May 12, 2026

OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

April 30, 2026

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

April 30, 2026

OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results

April 28, 2026

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

April 22, 2026

OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026

April 21, 2026

OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

April 7, 2026

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

February 26, 2026

OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results

February 26, 2026

OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26

February 12, 2026

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

February 3, 2026

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

January 5, 2026

Calls in 2026

Decks in 2026